Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03618992 · ClinicalTrials.gov registry record · NA

Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment

A NA study, sponsored by University of Arizona.

Terminated
Registry status
NA
Development phase
14
Enrollment target

NCT03618992 is a NA study that was terminated before completion, run by University of Arizona. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03618992, a NA study, was terminated before completion, sponsored by University of Arizona.

TERMINATED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

This will be a multi-visit study that will take approximately 3 hours in total. Up to 200 subjects from the BUMC Valley Fever and BUMC Dermatology clinics will be enrolled in this study and assigned to one of three cohorts according to timeline of oral anti-fungal therapy. Subjects in Cohort 1 will be randomized to apply topical cholesterol-containing moisturizers to the skin, hair and lips on either the right or left side of the body daily. Measurements of skin barrier function, appearance of skin and hair, and hair samples will be obtained at baseline and at 4 week follow-up visits. Cohorts 2 and 3 will be observational groups at differing points in oral antifungal treatment regimen. Subjects will be randomized to have measurements of skin barrier function and hair and skin characteristics obtained from either the right or left side of the body at baseline and at monthly follow-up visits.

Interventions

  • OTHER Cholesterol-containing moisturizers

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2018-08-01
Est. Completion 2020-05-31
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT03618992

The ClinicalTrials.gov registry entry for NCT03618992 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cholesterol-containing moisturizers is the first listed.

NCT03618992 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03618992 about?

NCT03618992 is a clinical study titled "Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment". This will be a multi-visit study that will take approximately 3 hours in total. Up to 200 subjects from the BUMC Valley Fever and BUMC Dermatology clinics will be enrolled in this study and assigned to one of three cohorts according to timeline of oral anti-fungal therapy. Subjects in Cohort 1 will ...

What is the current status of trial NCT03618992?

This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2018-08-01. Estimated completion is 2020-05-31.

What interventions are being tested in trial NCT03618992?

The interventions under investigation include: Cholesterol-containing moisturizers (OTHER).

Who is sponsoring clinical trial NCT03618992?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.